Contineum Therapeutics, Inc. (CTNM)

Contineum Therapeutics Analyst Ratings

• Total Analysts: 5
• Consensus Rating: Strong Buy
• Price Target: $20.00
• Upside: +57.73%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joel Beatty Baird	Baird	Buy Maintains $16 → $14	Buy	Maintains	$16 → $14	+10.41%	Nov 24, 2025
Brian Abrahams RBC Capital	RBC Capital	Buy Maintains $25 → $22	Buy	Maintains	$25 → $22	+73.50%	Nov 21, 2025
Faisal Khurshid Leerink Partners	Leerink Partners	Buy Initiates $20	Buy	Initiates	$20	+57.73%	Sep 25, 2025
Jeffrey Hung Morgan Stanley	Morgan Stanley	Buy Maintains $20 → $21	Buy	Maintains	$20 → $21	+65.62%	Aug 18, 2025
Jeffrey Hung Morgan Stanley	Morgan Stanley	Buy Maintains $25 → $20	Buy	Maintains	$25 → $20	+57.73%	May 19, 2025
Brian Abrahams RBC Capital	RBC Capital	Buy Reiterates $31	Buy	Reiterates	$31	+144.48%	May 15, 2025
Debanjana Chatterjee Jones Trading	Jones Trading	Strong Buy Initiates $23	Strong Buy	Initiates	$23	+81.39%	Mar 13, 2025
Jeffrey Hung Morgan Stanley	Morgan Stanley	Buy Initiates $25	Buy	Initiates	$25	+97.16%	Mar 7, 2025
Joel Beatty Baird	Baird	Buy Maintains $32 → $16	Buy	Maintains	$32 → $16	+26.18%	Mar 7, 2025
Brian Abrahams RBC Capital	RBC Capital	Buy Reiterates $31	Buy	Reiterates	$31	+144.48%	Jan 9, 2025
Brian Abrahams RBC Capital	RBC Capital	Buy Maintains $32 → $31	Buy	Maintains	$32 → $31	+144.48%	Nov 7, 2024
Joel Beatty Baird	Baird	Buy Initiates $32	Buy	Initiates	$32	+152.37%	Oct 22, 2024
Brian Abrahams RBC Capital	RBC Capital	Buy Maintains $30 → $32	Buy	Maintains	$30 → $32	+152.37%	Aug 14, 2024
Paul Matteis Stifel	Stifel	Strong Buy Initiates $29	Strong Buy	Initiates	$29	+128.71%	Apr 30, 2024
Brian Abrahams RBC Capital	RBC Capital	Buy Initiates $30	Buy	Initiates	$30	+136.59%	Apr 30, 2024
Jeffrey Hung Morgan Stanley	Morgan Stanley	Buy Initiates $25	Buy	Initiates	$25	+97.16%	Apr 30, 2024